Chiesi Pharmaceuticals in Austria

Chiesi Pharmaceuticals GmbH (formerly Torrex Chiesi Pharma GmbH) is a 100% subsidiary of the Italian family-owned company Chiesi Farmaceutici S.p.A. and is divided into three different business units.

The Chiesi Austria business unit is responsible for the local business, while the Multi-Country Organization (MCO), together with partners, oversees sales and marketing in the Baltic, Balkan and CIS regions. Six wholly owned subsidiaries (Bulgaria, Romania, Hungary, Slovenia, Slovakia and the Czech Republic) report to the CEE Hub, which is also located in Vienna.

Chiesi Group

The Chiesi Group is an international, research-oriented pharmaceutical and health company with headquarters in Parma, Italy. The company has over 85 years of experience and employs more than 6,000 people in 30 countries. Chiesi researches, develops and markets innovative drugs in its three therapeutic areas: AIR (products and services that promote respiration, from new-born to adult populations), RARE (treatment for patients with rare and ultra-rare diseases) and CARE (products and services that support special care and consumer-facing self-care).

Certified B Corp® 

Chiesi was successfully certified as a B Corp® company for the second time in a row in 2022. The company is committed to acting responsibly with regard to its employees, customers, suppliers, community and the environment. Its sustainability practices are measured and evaluated against the most ambitious global standards. The Chiesi Group has set a goal to become CO2 neutral by 2035. As a B Corp® in the pharmaceutical industry, Chiesi is among the companies leading a global movement for an inclusive, equitable and regenerative economy. 

For further information: www.chiesi.com